IDEXX Laboratories, Inc.

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 06/07/2024 am IST			5-day change	1st Jan Change
486 ^USD	+1.78%		-0.25%	-12.44%

24/06	Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520	MT
29/05	Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM

IDEXX Laboratories, Inc. Elects Stuart M. Essig as Board of Directors

January 08, 2018 at 10:35 pm IST

IDEXX Laboratories, Inc. elected Stuart M. Essig as Board of Directors.

Latest news about IDEXX Laboratories, Inc.

Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520	24/06	MT
Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM	29/05
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	14/05	MT
BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653	02/05	MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675	02/05	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570	02/05	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655	02/05	MT
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460	02/05	MT
Wall Street: heaviness prevails after a volatile episode	02/05	CF
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	02/05	CI
IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Transcript : IDEXX Laboratories, Inc., Q1 2024 Earnings Call, May 01, 2024	01/05
IDEXX Laboratories' Q1 Earnings, Revenue Increase	01/05	MT
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $964.1M, vs. Street Est of $965.8M	01/05	MT
Idexx Laboratories, Inc. Revises Earnings Guidance for 2024	01/05	CI
North American Morning Briefing : Traders Wait for -2-	01/05	DJ
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating	30/04	MT
Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	02/04	MT
Elanco appoints two directors after settling with activist Ancora	01/04	RE
Elanco appoints two directors to its board after agreement with Ancora	01/04	RE
Idexx Laboratories: Superior growth prospects	11/03
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing	08/03	MT
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing	08/03	MT
Transcript : IDEXX Laboratories, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 11:00 AM	04/03
Ancora seeks four board seats at Elanco amid push for changes	01/03	RE

Chart IDEXX Laboratories, Inc.

Duration

Period

More charts

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

06/08/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company